Assetmark Inc. Acquires 96 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Assetmark Inc. lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 5.5% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,834 shares of the company’s stock after purchasing an additional 96 shares during the period. Assetmark Inc.’s holdings in HCA Healthcare were worth $746,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in the company. MFA Wealth Advisors LLC acquired a new stake in shares of HCA Healthcare in the 2nd quarter valued at $27,000. Unique Wealth Strategies LLC bought a new position in shares of HCA Healthcare in the 2nd quarter worth about $28,000. Bangor Savings Bank raised its stake in HCA Healthcare by 112.5% during the 2nd quarter. Bangor Savings Bank now owns 85 shares of the company’s stock worth $27,000 after buying an additional 45 shares during the period. GPS Wealth Strategies Group LLC increased its holdings in HCA Healthcare by 284.0% during the 2nd quarter. GPS Wealth Strategies Group LLC now owns 96 shares of the company’s stock worth $31,000 after purchasing an additional 71 shares in the last quarter. Finally, Capital Performance Advisors LLP purchased a new position in HCA Healthcare in the third quarter valued at approximately $41,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

HCA stock opened at $342.96 on Friday. The firm has a 50 day moving average price of $386.00 and a 200-day moving average price of $357.03. HCA Healthcare, Inc. has a 52-week low of $238.82 and a 52-week high of $417.14. The firm has a market capitalization of $86.87 billion, a price-to-earnings ratio of 15.40, a PEG ratio of 1.34 and a beta of 1.68. The company has a debt-to-equity ratio of 48.71, a quick ratio of 1.00 and a current ratio of 1.12.

HCA Healthcare Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a dividend of $0.66 per share. This represents a $2.64 annualized dividend and a dividend yield of 0.77%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio (DPR) is currently 11.85%.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Erol R. Akdamar sold 2,900 shares of HCA Healthcare stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This trade represents a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 15,155 shares of company stock valued at $5,608,990 over the last 90 days. Corporate insiders own 1.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the company. Truist Financial increased their target price on HCA Healthcare from $390.00 to $430.00 and gave the stock a “buy” rating in a research report on Monday, August 19th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $392.00 price objective on shares of HCA Healthcare in a research note on Tuesday, October 1st. Wells Fargo & Company raised their price objective on HCA Healthcare from $395.00 to $400.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 6th. Leerink Partners raised their price objective on HCA Healthcare from $367.00 to $396.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Finally, Barclays cut their target price on HCA Healthcare from $396.00 to $392.00 and set an “overweight” rating on the stock in a research note on Friday, November 8th. Five research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $385.00.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.